Login
Home
Charts
Search
Watchlist
Products

Citurgia Biochemicals Ltd

CITURGIA·BSE
105.500.00%Mon, 21 Sept '26

Citurgia Biochemicals Ltd

CITURGIA
BSE
105.50
0.00%
|Mon, 21 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,394Cr
Close
Close Price
105.50
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
PS
Price To Sales
Revenue
Revenue
0Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
-68.18%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-50.0-10.07.10.06.79.17.711.121.4-190.0-116.70.0
NPM
NPM%
EPS
EPS
0.00.00.00.00.00.00.00.00.00.00.00.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
000000000000
Operating Profit
Operating ProfitCr
000000000000
OPM
OPM%
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
000000000000
Tax
TaxCr
000000000000
PAT
PATCr
000000000000
Growth YoY
PAT Growth YoY%
-50.0-10.07.10.06.79.17.711.121.4-190.0-116.70.0
NPM
NPM%
EPS
EPS
0.00.00.00.00.00.00.00.00.00.00.00.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000000000000
Growth
Revenue Growth%
Expenses
ExpensesCr
000000000011
Operating Profit
Operating ProfitCr
0000000000-1-1
OPM
OPM%
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
100000000000
PBT
PBTCr
-1-1-1-10-10000-1-1
Tax
TaxCr
000000000000
PAT
PATCr
-1-1-1-10-10000-1-1
Growth
PAT Growth%
13.019.2-3.6-1.329.5-54.534.0-7.9-9.011.0-74.9-68.2
NPM
NPM%
EPS
EPS
-0.3-0.2-0.2-0.2-0.1-0.2-0.1-0.2-0.2-0.2-0.10.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
000000000000
Growth
Revenue Growth%
Expenses
ExpensesCr
000000000011
Operating Profit
Operating ProfitCr
0000000000-1-1
OPM
OPM%
Other Income
Other IncomeCr
00000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
100000000000
PBT
PBTCr
-1-1-1-10-10000-1-1
Tax
TaxCr
000000000000
PAT
PATCr
-1-1-1-10-10000-1-1
Growth
PAT Growth%
13.019.2-3.6-1.329.5-54.534.0-7.9-9.011.0-74.9-68.2
NPM
NPM%
EPS
EPS
-0.3-0.2-0.2-0.2-0.1-0.2-0.1-0.2-0.2-0.2-0.10.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2626262626262626262626
Reserves
ReservesCr
-32-32-33-33-34-34-35-35-35-36-37
Current Liabilities
Current LiabilitiesCr
888889999910
Non Current Liabilities
Non Current LiabilitiesCr
67888888999
Total Liabilities
Total LiabilitiesCr
1212131212121111111110
Current Assets
Current AssetsCr
67888888888
Non Current Assets
Non Current AssetsCr
55444333322
Total Assets
Total AssetsCr
1212131212121111111110
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
2626262626262626262626
Reserves
ReservesCr
-32-32-33-33-34-34-35-35-35-36-37
Current Liabilities
Current LiabilitiesCr
888889999910
Non Current Liabilities
Non Current LiabilitiesCr
67888888999
Total Liabilities
Total LiabilitiesCr
1212131212121111111110
Current Assets
Current AssetsCr
67888888888
Non Current Assets
Non Current AssetsCr
55444333322
Total Assets
Total AssetsCr
1212131212121111111110

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-1-100000000
Investing Cash Flow
Investing Cash FlowCr
00000000000
Financing Cash Flow
Financing Cash FlowCr
01100000000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
0-1-10000000
CFO To PAT
CFO To PAT%
11.795.4237.833.928.524.27.015.529.827.417.6
CFO To EBITDA
CFO To EBITDA%
48.0492.7723.379.495.839.716.032.156.758.725.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0-1-100000000
Investing Cash Flow
Investing Cash FlowCr
00000000000
Financing Cash Flow
Financing Cash FlowCr
01100000000
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
0-1-10000000
CFO To PAT
CFO To PAT%
11.795.4237.833.928.524.27.015.529.827.417.6
CFO To EBITDA
CFO To EBITDA%
48.0492.7723.379.495.839.716.032.156.758.725.5

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,3041,394
Price To Earnings
Price To Earnings
-3,113.2
Price To Sales
Price To Sales
Price To Book
Price To Book
-225.2-137.0
EV To EBITDA
EV To EBITDA
-4,530.4-2,773.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
NPM
NPM%
ROCE
ROCE%
112.5113.0-204.6215.060.048.724.321.420.715.922.222.2
ROE
ROE%
13.09.59.08.35.57.95.05.15.24.57.27.2
ROA
ROA%
-5.7-4.5-4.3-4.5-3.3-5.3-3.5-3.9-4.3-3.9-7.1-7.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,3041,394
Price To Earnings
Price To Earnings
-3,113.2
Price To Sales
Price To Sales
Price To Book
Price To Book
-225.2-137.0
EV To EBITDA
EV To EBITDA
-4,530.4-2,773.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
OPM
OPM%
NPM
NPM%
ROCE
ROCE%
112.5113.0-204.6215.060.048.724.321.420.715.922.222.2
ROE
ROE%
13.09.59.08.35.57.95.05.15.24.57.27.2
ROA
ROA%
-5.7-4.5-4.3-4.5-3.3-5.3-3.5-3.9-4.3-3.9-7.1-7.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Citurgia Biochemicals is a chemical manufacturer that has not manufactured anything in more than twenty years. Incorporated in 1974 to produce basic chemicals, its sole operating division-a calcium carbonate plant in Rishikesh-has been shut since a lockout was declared in September 2003, and the company has earned no revenue in any recent financial year. Everything the company does now is about resolving the legal and regulatory knots that keep it suspended: a Rehabilitation Scheme approved by the Board for Industrial and Financial Reconstruction but stayed by the Uttarakhand High Court, an environmental clearance that has never been granted, and a stock that has not traded on the BSE since January 2013. # Business segments One suspended plant, no revenue, and a single division that exists only on paper-the entire business is a legacy asset waiting for a court verdict. ## 1. Calcium carbonate: a plant that has not run in two decades **The company's only operating division has produced nothing and sold nothing since a lockout began in 2003, and it cannot restart without an environmental clearance that remains out of reach.** - **Locked out since 2003** - the Rishikesh factory was shut under a formal lockout on 29 September 2003, and that lockout has never been lifted. - **No environmental green light** - operations cannot resume because the Uttarakhand Environment Protection and Pollution Control Board has not given clearance, so the Board of Directors says it cannot even draw up future plans. - **No working capital** - even if the legal hurdles were cleared, the company lacks the money to restart, and it has not earned any revenue in any year under recent report. - **A rehabilitation scheme in limbo** - a revival plan was passed by the BIFR, but the Uttarakhand High Court stayed it; the company has appealed to the Supreme Court, and the matter is still pending. - **Two employees, no production** - the entire workforce consists of two permanent employees on the rolls, and as of March 2020 the company held no inventory at all. # Group structure and partners **A tightly held shell with no subsidiaries, no joint ventures, and promoters who own virtually every share-though a sliver of legacy shareholders has just been formally cut loose.** - **99.67% promoter-held** - of the 132 million shares outstanding, promoters and their group hold 131.7 million, leaving public shareholders with just 430,070 shares, or 0.33% of the company. - **One dominant promoter** - Satya Sheel Engineers And Miners Pvt Ltd alone owns 60.64% of the equity. - **No corporate family** - the company has no holding company, no subsidiaries, no associates, and no joint ventures. - **Stock frozen since 2013** - trading in the equity shares has been suspended by SEBI since 16 January 2013, though the company received in-principle approval from the BSE for revocation of that suspension in August 2025.

Documents — Citurgia Biochemicals Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/z3hwc5ag4xf703bhtzu5n3pu.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/jdkd1xiumrq7jivhh8om80q7.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/2xkud9lcb0kqju6poy3kjbr0.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/ave0gr37jop550zfhrykiurx.pdf
  • Q1 FY2021 Quarterly Result (Jun 2020, PDF): https://www.stockscans.in/document/4ufmmkiyi3d7mhgfhifmif0w.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/5cbd60d5u5oyv69dqgwn15t5.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/msuendc9y24b91i7xe6rnqs8.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/yk2zwtlx7cw5lamdjecjo93t.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/o3x0so4tti106zs6n3hrdyzl.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/iui3eo0ysx0j590y18j024ov.pdf